| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Integration | 91 | 2022 | 299 | 16.950 |
Why?
|
| HIV Integrase | 65 | 2022 | 120 | 13.080 |
Why?
|
| HIV-1 | 144 | 2023 | 6939 | 10.680 |
Why?
|
| HIV Integrase Inhibitors | 21 | 2023 | 142 | 5.990 |
Why?
|
| Integrases | 43 | 2022 | 533 | 5.750 |
Why?
|
| DNA, Viral | 54 | 2022 | 2225 | 5.160 |
Why?
|
| Capsid | 25 | 2023 | 436 | 4.730 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 16 | 2022 | 98 | 3.640 |
Why?
|
| Virus Replication | 53 | 2022 | 2534 | 3.480 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 27 | 2022 | 1676 | 3.400 |
Why?
|
| Capsid Proteins | 20 | 2023 | 479 | 2.620 |
Why?
|
| Retroviridae | 13 | 2022 | 914 | 2.550 |
Why?
|
| Host-Pathogen Interactions | 19 | 2022 | 1477 | 2.440 |
Why?
|
| Active Transport, Cell Nucleus | 17 | 2023 | 443 | 2.060 |
Why?
|
| Nuclear Pore Complex Proteins | 10 | 2023 | 165 | 1.870 |
Why?
|
| Spumavirus | 9 | 2020 | 16 | 1.820 |
Why?
|
| Adaptor Proteins, Signal Transducing | 16 | 2021 | 2916 | 1.690 |
Why?
|
| HIV Infections | 45 | 2023 | 16718 | 1.620 |
Why?
|
| Cell Nucleus | 14 | 2023 | 2969 | 1.470 |
Why?
|
| beta Karyopherins | 5 | 2019 | 47 | 1.320 |
Why?
|
| Human Immunodeficiency Virus Proteins | 5 | 2021 | 65 | 1.310 |
Why?
|
| Virus Uncoating | 4 | 2022 | 13 | 1.160 |
Why?
|
| Protein Conformation | 18 | 2021 | 4011 | 1.130 |
Why?
|
| Pyridones | 3 | 2021 | 712 | 1.120 |
Why?
|
| Virus Latency | 7 | 2021 | 358 | 1.110 |
Why?
|
| Cryoelectron Microscopy | 10 | 2021 | 571 | 1.040 |
Why?
|
| Protein Multimerization | 12 | 2021 | 970 | 1.010 |
Why?
|
| Lentivirus | 5 | 2022 | 501 | 1.000 |
Why?
|
| Cell Line | 46 | 2023 | 15997 | 0.980 |
Why?
|
| Transcription Factors | 18 | 2021 | 12208 | 0.970 |
Why?
|
| Chromatin | 9 | 2022 | 2934 | 0.910 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 3 | 2019 | 222 | 0.910 |
Why?
|
| Protein Binding | 31 | 2021 | 9386 | 0.900 |
Why?
|
| Recombination, Genetic | 9 | 2015 | 1586 | 0.890 |
Why?
|
| Virion | 13 | 2022 | 433 | 0.890 |
Why?
|
| Anti-HIV Agents | 12 | 2022 | 4256 | 0.870 |
Why?
|
| Catalytic Domain | 13 | 2022 | 698 | 0.860 |
Why?
|
| Models, Molecular | 25 | 2022 | 5456 | 0.860 |
Why?
|
| HeLa Cells | 25 | 2021 | 3128 | 0.840 |
Why?
|
| HEK293 Cells | 27 | 2021 | 4204 | 0.840 |
Why?
|
| Moloney murine leukemia virus | 2 | 2014 | 139 | 0.830 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2020 | 215 | 0.800 |
Why?
|
| Polyadenylation | 2 | 2019 | 117 | 0.790 |
Why?
|
| DNA Nucleotidyltransferases | 12 | 1996 | 193 | 0.780 |
Why?
|
| Viral Proteins | 10 | 2017 | 1900 | 0.770 |
Why?
|
| Proviruses | 10 | 2023 | 318 | 0.760 |
Why?
|
| Nuclear Pore | 5 | 2023 | 70 | 0.750 |
Why?
|
| Nucleoproteins | 2 | 2013 | 115 | 0.740 |
Why?
|
| DNA, Complementary | 8 | 2007 | 2050 | 0.720 |
Why?
|
| Primates | 2 | 2020 | 545 | 0.700 |
Why?
|
| Crystallography, X-Ray | 16 | 2021 | 2011 | 0.700 |
Why?
|
| Cyclophilin A | 6 | 2021 | 57 | 0.690 |
Why?
|
| Oxazines | 2 | 2020 | 298 | 0.690 |
Why?
|
| RNA-Binding Proteins | 4 | 2022 | 1903 | 0.680 |
Why?
|
| Gene Targeting | 4 | 2018 | 880 | 0.670 |
Why?
|
| Drug Resistance, Viral | 8 | 2020 | 820 | 0.660 |
Why?
|
| Leukemia Virus, Murine | 10 | 2019 | 117 | 0.640 |
Why?
|
| Virus Assembly | 8 | 2021 | 144 | 0.630 |
Why?
|
| Simian immunodeficiency virus | 3 | 2020 | 846 | 0.620 |
Why?
|
| Nuclear Localization Signals | 4 | 2006 | 80 | 0.620 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2022 | 61 | 0.610 |
Why?
|
| DNA | 18 | 2023 | 7301 | 0.610 |
Why?
|
| HIV Seropositivity | 3 | 2023 | 971 | 0.600 |
Why?
|
| Allosteric Regulation | 11 | 2023 | 408 | 0.580 |
Why?
|
| Nuclear Proteins | 10 | 2022 | 5853 | 0.560 |
Why?
|
| Binding Sites | 20 | 2020 | 6114 | 0.550 |
Why?
|
| Integrase Inhibitors | 3 | 2021 | 12 | 0.550 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 2232 | 0.540 |
Why?
|
| RNA, Viral | 9 | 2023 | 2902 | 0.510 |
Why?
|
| Jurkat Cells | 6 | 2021 | 743 | 0.490 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2023 | 4386 | 0.470 |
Why?
|
| Antiviral Agents | 5 | 2023 | 2987 | 0.470 |
Why?
|
| HIV | 5 | 2011 | 1604 | 0.470 |
Why?
|
| Humans | 146 | 2023 | 744343 | 0.470 |
Why?
|
| Structure-Activity Relationship | 11 | 2021 | 3129 | 0.430 |
Why?
|
| Molecular Sequence Data | 31 | 2013 | 18111 | 0.420 |
Why?
|
| Protein Structure, Tertiary | 13 | 2017 | 3846 | 0.410 |
Why?
|
| Polymerase Chain Reaction | 12 | 2016 | 6171 | 0.400 |
Why?
|
| Genome, Viral | 5 | 2021 | 667 | 0.400 |
Why?
|
| DNA-Binding Proteins | 10 | 2014 | 9648 | 0.390 |
Why?
|
| Amino Acid Sequence | 23 | 2014 | 13815 | 0.380 |
Why?
|
| Catalysis | 7 | 2015 | 761 | 0.380 |
Why?
|
| Macromolecular Substances | 3 | 2013 | 1454 | 0.380 |
Why?
|
| Piperazines | 2 | 2020 | 2488 | 0.370 |
Why?
|
| Reverse Transcription | 8 | 2020 | 47 | 0.360 |
Why?
|
| Karyopherins | 2 | 2009 | 137 | 0.350 |
Why?
|
| Mutation | 30 | 2021 | 29786 | 0.350 |
Why?
|
| Animals | 53 | 2022 | 168757 | 0.340 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2007 | 1723 | 0.340 |
Why?
|
| Simian virus 40 | 2 | 2007 | 295 | 0.340 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2021 | 442 | 0.330 |
Why?
|
| Leukemia, Experimental | 2 | 2019 | 246 | 0.320 |
Why?
|
| Mutation, Missense | 7 | 2014 | 2564 | 0.320 |
Why?
|
| HIV Antigens | 1 | 2009 | 347 | 0.320 |
Why?
|
| Retroviridae Infections | 2 | 2019 | 151 | 0.310 |
Why?
|
| HIV Reverse Transcriptase | 3 | 2021 | 213 | 0.310 |
Why?
|
| Transcription, Genetic | 10 | 2016 | 7722 | 0.300 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 4740 | 0.300 |
Why?
|
| Synaptic Membranes | 1 | 2007 | 91 | 0.290 |
Why?
|
| Abelson murine leukemia virus | 4 | 1990 | 43 | 0.290 |
Why?
|
| Adaptive Immunity | 3 | 2016 | 713 | 0.280 |
Why?
|
| Base Sequence | 18 | 2015 | 12797 | 0.280 |
Why?
|
| Directed Molecular Evolution | 1 | 2007 | 160 | 0.280 |
Why?
|
| Cytoplasm | 4 | 2021 | 1539 | 0.280 |
Why?
|
| Nucleosomes | 3 | 2017 | 494 | 0.270 |
Why?
|
| Mucoproteins | 1 | 2005 | 50 | 0.270 |
Why?
|
| Genomics | 2 | 2021 | 5720 | 0.270 |
Why?
|
| Virus Internalization | 4 | 2021 | 501 | 0.250 |
Why?
|
| Nucleic Acid Conformation | 6 | 2021 | 913 | 0.240 |
Why?
|
| Recombinant Proteins | 10 | 2019 | 6622 | 0.240 |
Why?
|
| Gene Products, vpr | 4 | 2005 | 36 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.230 |
Why?
|
| Genome, Human | 2 | 2016 | 4420 | 0.220 |
Why?
|
| Growth Substances | 1 | 2005 | 784 | 0.220 |
Why?
|
| Multiprotein Complexes | 2 | 2021 | 1119 | 0.220 |
Why?
|
| Lens, Crystalline | 1 | 2004 | 388 | 0.210 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 4 | 2009 | 39 | 0.210 |
Why?
|
| Acetates | 2 | 2014 | 311 | 0.210 |
Why?
|
| Binding, Competitive | 2 | 2019 | 1157 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2012 | 1877 | 0.210 |
Why?
|
| HIV Long Terminal Repeat | 3 | 2011 | 88 | 0.210 |
Why?
|
| Heart | 1 | 2015 | 4467 | 0.210 |
Why?
|
| Amino Acid Substitution | 8 | 2020 | 1791 | 0.200 |
Why?
|
| Rous sarcoma virus | 1 | 2021 | 4 | 0.200 |
Why?
|
| Mice | 22 | 2022 | 81183 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4751 | 0.200 |
Why?
|
| Retroviridae Proteins | 2 | 1993 | 98 | 0.190 |
Why?
|
| RNA, Messenger | 5 | 2019 | 13033 | 0.190 |
Why?
|
| Prions | 1 | 2022 | 180 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2019 | 2455 | 0.190 |
Why?
|
| Interphase | 1 | 2021 | 226 | 0.190 |
Why?
|
| Amides | 2 | 2020 | 459 | 0.190 |
Why?
|
| Pyrrolidinones | 2 | 2011 | 117 | 0.180 |
Why?
|
| HIV-2 | 3 | 2009 | 167 | 0.180 |
Why?
|
| Gene Products, pol | 2 | 2017 | 47 | 0.180 |
Why?
|
| Nucleocapsid Proteins | 2 | 2021 | 77 | 0.180 |
Why?
|
| Gene Products, gag | 2 | 2017 | 337 | 0.180 |
Why?
|
| DNA Footprinting | 4 | 2000 | 98 | 0.180 |
Why?
|
| Conserved Sequence | 4 | 2004 | 1202 | 0.180 |
Why?
|
| Horses | 1 | 2020 | 304 | 0.180 |
Why?
|
| Sequence Deletion | 7 | 2009 | 1526 | 0.180 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2021 | 615 | 0.170 |
Why?
|
| Viral Fusion Proteins | 1 | 2019 | 95 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 474 | 0.170 |
Why?
|
| Phenylalanine | 2 | 2022 | 365 | 0.170 |
Why?
|
| Evolution, Molecular | 3 | 2020 | 1940 | 0.170 |
Why?
|
| Cats | 1 | 2020 | 998 | 0.170 |
Why?
|
| Magnesium | 3 | 2020 | 813 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2017 | 3772 | 0.170 |
Why?
|
| Awards and Prizes | 1 | 2023 | 375 | 0.170 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 4584 | 0.160 |
Why?
|
| Viral Matrix Proteins | 1 | 2019 | 186 | 0.160 |
Why?
|
| Quinolines | 2 | 2014 | 732 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2021 | 8436 | 0.160 |
Why?
|
| Cattle | 3 | 2020 | 3922 | 0.160 |
Why?
|
| Protein Structure, Quaternary | 3 | 2016 | 436 | 0.160 |
Why?
|
| Fluoroimmunoassay | 1 | 2017 | 33 | 0.160 |
Why?
|
| Gene Silencing | 2 | 2020 | 1538 | 0.160 |
Why?
|
| Attachment Sites, Microbiological | 1 | 1997 | 26 | 0.160 |
Why?
|
| Heterochromatin | 1 | 2020 | 296 | 0.160 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 513 | 0.160 |
Why?
|
| Mutagenesis | 4 | 2006 | 1266 | 0.150 |
Why?
|
| DNA Transposable Elements | 1 | 2001 | 748 | 0.150 |
Why?
|
| Genetic Vectors | 2 | 2019 | 3420 | 0.150 |
Why?
|
| DNA Helicases | 1 | 2003 | 859 | 0.150 |
Why?
|
| Quinolones | 2 | 2011 | 367 | 0.150 |
Why?
|
| Solubility | 4 | 2013 | 1085 | 0.150 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 1996 | 4 | 0.150 |
Why?
|
| Cloning, Molecular | 6 | 2005 | 4320 | 0.150 |
Why?
|
| Alternative Splicing | 2 | 2017 | 1117 | 0.150 |
Why?
|
| Receptors, Virus | 1 | 2000 | 648 | 0.140 |
Why?
|
| Tumor Virus Infections | 1 | 2019 | 452 | 0.140 |
Why?
|
| Fluorescence | 1 | 2019 | 751 | 0.140 |
Why?
|
| Repressor Proteins | 5 | 2020 | 3023 | 0.140 |
Why?
|
| Pyridines | 2 | 2019 | 2825 | 0.140 |
Why?
|
| Birds | 2 | 2009 | 163 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 2021 | 1364 | 0.140 |
Why?
|
| Consensus Sequence | 2 | 2007 | 377 | 0.140 |
Why?
|
| Manganese | 2 | 1996 | 408 | 0.140 |
Why?
|
| Chromatography, Gel | 5 | 2014 | 668 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1375 | 0.130 |
Why?
|
| Genetic Complementation Test | 3 | 2005 | 562 | 0.130 |
Why?
|
| Macrophages | 6 | 2021 | 5655 | 0.130 |
Why?
|
| Blotting, Western | 4 | 2014 | 5179 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2017 | 14557 | 0.130 |
Why?
|
| RNA | 2 | 2022 | 2749 | 0.130 |
Why?
|
| Sulfolobus solfataricus | 1 | 2014 | 2 | 0.130 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 294 | 0.130 |
Why?
|
| Staining and Labeling | 2 | 2009 | 1100 | 0.130 |
Why?
|
| Amino Acid Motifs | 2 | 2016 | 936 | 0.130 |
Why?
|
| Archaeal Proteins | 1 | 2014 | 56 | 0.120 |
Why?
|
| Virus Activation | 1 | 2016 | 319 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2017 | 3386 | 0.120 |
Why?
|
| Mutant Proteins | 2 | 2014 | 500 | 0.120 |
Why?
|
| Models, Chemical | 1 | 2016 | 626 | 0.120 |
Why?
|
| Macaca mulatta | 1 | 2020 | 2375 | 0.120 |
Why?
|
| Gene Deletion | 4 | 2007 | 2751 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2017 | 360 | 0.120 |
Why?
|
| Allosteric Site | 1 | 2013 | 103 | 0.120 |
Why?
|
| Escherichia coli | 6 | 2015 | 4217 | 0.110 |
Why?
|
| Fetal Death | 1 | 2015 | 448 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
| RNA Interference | 4 | 2011 | 2889 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1655 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5867 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2015 | 488 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1999 | 708 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2006 | 7880 | 0.110 |
Why?
|
| Protein Structure, Secondary | 3 | 2005 | 1246 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2839 | 0.110 |
Why?
|
| DNA Primers | 4 | 2011 | 2892 | 0.110 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 407 | 0.110 |
Why?
|
| Histidine | 3 | 2020 | 313 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 595 | 0.100 |
Why?
|
| Homeodomain Proteins | 3 | 2017 | 2421 | 0.100 |
Why?
|
| Virus Release | 1 | 2012 | 39 | 0.100 |
Why?
|
| Transfection | 4 | 2004 | 5892 | 0.100 |
Why?
|
| Cells, Cultured | 8 | 2021 | 19229 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 588 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2017 | 850 | 0.100 |
Why?
|
| Substrate Specificity | 6 | 2015 | 1801 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2017 | 2504 | 0.100 |
Why?
|
| Hematopoiesis | 2 | 2017 | 2072 | 0.100 |
Why?
|
| HMGA1a Protein | 2 | 2003 | 64 | 0.100 |
Why?
|
| Dimerization | 1 | 2012 | 893 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1990 | 2942 | 0.090 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1990 | 77 | 0.090 |
Why?
|
| Cyclosporine | 2 | 2011 | 786 | 0.090 |
Why?
|
| Protein Engineering | 1 | 2014 | 540 | 0.090 |
Why?
|
| Sumoylation | 1 | 2011 | 83 | 0.090 |
Why?
|
| Guanosine Triphosphate | 2 | 2017 | 321 | 0.090 |
Why?
|
| Temperature | 5 | 2004 | 2206 | 0.090 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2010 | 17 | 0.090 |
Why?
|
| Kinetics | 5 | 2002 | 6473 | 0.090 |
Why?
|
| Models, Biological | 3 | 2021 | 9583 | 0.090 |
Why?
|
| Metals | 1 | 2014 | 719 | 0.090 |
Why?
|
| Peptide Fragments | 3 | 2020 | 5097 | 0.090 |
Why?
|
| Uracil | 1 | 2011 | 165 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 795 | 0.090 |
Why?
|
| Visna-maedi virus | 1 | 2009 | 7 | 0.090 |
Why?
|
| HIV Core Protein p24 | 1 | 2010 | 256 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2014 | 2256 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1703 | 0.090 |
Why?
|
| Retroelements | 1 | 2011 | 164 | 0.090 |
Why?
|
| Transposases | 3 | 2015 | 107 | 0.090 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 321 | 0.090 |
Why?
|
| Histones | 2 | 2017 | 2599 | 0.090 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2009 | 19 | 0.090 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2009 | 28 | 0.090 |
Why?
|
| Genome | 2 | 2015 | 1808 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2021 | 2958 | 0.080 |
Why?
|
| Biotinylation | 1 | 2009 | 179 | 0.080 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2009 | 71 | 0.080 |
Why?
|
| Carrier State | 1 | 2012 | 518 | 0.080 |
Why?
|
| Zidovudine | 1 | 2010 | 620 | 0.080 |
Why?
|
| Viral Envelope Proteins | 1 | 2012 | 635 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1838 | 0.080 |
Why?
|
| DNA Shuffling | 1 | 2007 | 5 | 0.080 |
Why?
|
| Glycine | 2 | 2022 | 671 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2009 | 180 | 0.080 |
Why?
|
| Indoles | 1 | 2016 | 1839 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 905 | 0.080 |
Why?
|
| Luciferases | 1 | 2009 | 733 | 0.080 |
Why?
|
| Nucleoside Deaminases | 1 | 2007 | 58 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 2007 | 0.080 |
Why?
|
| Genes, ras | 1 | 1990 | 690 | 0.080 |
Why?
|
| Fibroblasts | 3 | 2012 | 4161 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 789 | 0.070 |
Why?
|
| Crows | 1 | 2006 | 5 | 0.070 |
Why?
|
| Coenzymes | 1 | 2007 | 91 | 0.070 |
Why?
|
| AT-Hook Motifs | 1 | 2006 | 2 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2004 | 258 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2005 | 3494 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 12072 | 0.070 |
Why?
|
| Crystallization | 2 | 2005 | 524 | 0.070 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10180 | 0.070 |
Why?
|
| Restriction Mapping | 2 | 2005 | 878 | 0.070 |
Why?
|
| Plasmids | 3 | 2011 | 2307 | 0.070 |
Why?
|
| Models, Animal | 1 | 2012 | 2171 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 190 | 0.070 |
Why?
|
| Gene Expression | 3 | 2013 | 7799 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1547 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 1736 | 0.060 |
Why?
|
| Adenine | 1 | 2010 | 936 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2012 | 5021 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 798 | 0.060 |
Why?
|
| Defective Viruses | 2 | 1995 | 112 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2013 | 2967 | 0.060 |
Why?
|
| Stereoisomerism | 2 | 2019 | 624 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1341 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2126 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2001 | 1085 | 0.060 |
Why?
|
| Nucleotides | 2 | 2020 | 464 | 0.060 |
Why?
|
| HIV Protease | 1 | 2005 | 96 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2017 | 2924 | 0.060 |
Why?
|
| alpha Karyopherins | 1 | 2004 | 41 | 0.060 |
Why?
|
| ran GTP-Binding Protein | 1 | 2004 | 54 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1878 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 3505 | 0.060 |
Why?
|
| Oncogenes | 1 | 1990 | 1265 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 349 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3752 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2012 | 1873 | 0.060 |
Why?
|
| Polysaccharide-Lyases | 1 | 2003 | 48 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2005 | 4186 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2004 | 573 | 0.060 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 2012 | 248 | 0.060 |
Why?
|
| CpG Islands | 1 | 2007 | 1172 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2017 | 11483 | 0.050 |
Why?
|
| Circular Dichroism | 2 | 2000 | 354 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2017 | 4554 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2003 | 192 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 1801 | 0.050 |
Why?
|
| Myocardium | 1 | 2015 | 4776 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 829 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 1050 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 589 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 16689 | 0.050 |
Why?
|
| Serine | 2 | 2020 | 826 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2005 | 810 | 0.050 |
Why?
|
| Cricetinae | 2 | 2020 | 2472 | 0.050 |
Why?
|
| DNA Repair | 2 | 2016 | 2046 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 853 | 0.050 |
Why?
|
| Phytic Acid | 1 | 2020 | 23 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2022 | 563 | 0.050 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 28 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 21827 | 0.050 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2020 | 30 | 0.050 |
Why?
|
| Gene Products, rev | 1 | 2000 | 31 | 0.050 |
Why?
|
| Disease Reservoirs | 1 | 2021 | 131 | 0.050 |
Why?
|
| Drug Design | 2 | 2017 | 1076 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2004 | 23403 | 0.050 |
Why?
|
| DNA, Satellite | 1 | 2020 | 69 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2021 | 249 | 0.050 |
Why?
|
| Viral Core Proteins | 1 | 2020 | 162 | 0.050 |
Why?
|
| Drugs, Investigational | 1 | 2022 | 214 | 0.050 |
Why?
|
| Viremia | 1 | 2023 | 736 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 336 | 0.050 |
Why?
|
| Peptide Mapping | 2 | 2007 | 263 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2000 | 138 | 0.050 |
Why?
|
| Virology | 1 | 2020 | 77 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 1338 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2020 | 196 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2009 | 2440 | 0.040 |
Why?
|
| Nucleocapsid | 1 | 2019 | 59 | 0.040 |
Why?
|
| Computational Biology | 3 | 2010 | 3521 | 0.040 |
Why?
|
| Aotidae | 2 | 2012 | 59 | 0.040 |
Why?
|
| DNA Replication | 2 | 2020 | 1399 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 913 | 0.040 |
Why?
|
| Centromere | 1 | 2020 | 220 | 0.040 |
Why?
|
| Mammals | 1 | 2005 | 1143 | 0.040 |
Why?
|
| Sheep | 1 | 2022 | 1437 | 0.040 |
Why?
|
| Protein Folding | 2 | 2000 | 843 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2020 | 367 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1186 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 164 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2005 | 879 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 3798 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2006 | 3002 | 0.040 |
Why?
|
| Rats | 3 | 2021 | 24260 | 0.040 |
Why?
|
| Genes, pol | 2 | 1995 | 51 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 738 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2088 | 0.040 |
Why?
|
| Genes, myc | 1 | 2019 | 399 | 0.040 |
Why?
|
| Chromatography, Affinity | 2 | 1996 | 549 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3589 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1998 | 187 | 0.040 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1998 | 154 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 634 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 3462 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
| Spodoptera | 1 | 2017 | 153 | 0.040 |
Why?
|
| Poly A | 1 | 2017 | 185 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2020 | 381 | 0.040 |
Why?
|
| Monocytes | 3 | 2021 | 2596 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2203 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 551 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 2699 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 578 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 274 | 0.040 |
Why?
|
| Rabbits | 1 | 2003 | 4894 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2005 | 3760 | 0.040 |
Why?
|
| Suppression, Genetic | 1 | 1996 | 196 | 0.040 |
Why?
|
| Dogs | 1 | 2021 | 3912 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 2016 | 97 | 0.030 |
Why?
|
| Static Electricity | 1 | 2017 | 267 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 5524 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1917 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2716 | 0.030 |
Why?
|
| Bacteriophage M13 | 1 | 2015 | 39 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2022 | 1783 | 0.030 |
Why?
|
| AT Rich Sequence | 1 | 2015 | 11 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2540 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.030 |
Why?
|
| Turkeys | 1 | 1994 | 48 | 0.030 |
Why?
|
| DNA, Superhelical | 1 | 2015 | 50 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 345 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1999 | 752 | 0.030 |
Why?
|
| Schools | 1 | 2023 | 1433 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 208 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 809 | 0.030 |
Why?
|
| Viral Load | 1 | 2023 | 3299 | 0.030 |
Why?
|
| COS Cells | 1 | 1996 | 1161 | 0.030 |
Why?
|
| Endothelium | 1 | 2017 | 778 | 0.030 |
Why?
|
| Photochemistry | 1 | 1994 | 238 | 0.030 |
Why?
|
| Proteins | 2 | 2008 | 6103 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 305 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 712 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2014 | 420 | 0.030 |
Why?
|
| Point Mutation | 2 | 1996 | 1623 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2017 | 907 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2016 | 5974 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1994 | 354 | 0.030 |
Why?
|
| Polynucleotide 5'-Hydroxyl-Kinase | 1 | 1991 | 8 | 0.030 |
Why?
|
| Indoleacetic Acids | 1 | 2012 | 44 | 0.030 |
Why?
|
| Cell Division | 2 | 2012 | 4568 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1996 | 1899 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 739 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18029 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 2645 | 0.020 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2011 | 31 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 1993 | 220 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1341 | 0.020 |
Why?
|
| Protein Transport | 2 | 2009 | 1988 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 1990 | 20 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2014 | 572 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4803 | 0.020 |
Why?
|
| Water | 1 | 1996 | 1395 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8301 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2012 | 1861 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1990 | 146 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1990 | 457 | 0.020 |
Why?
|
| Female | 5 | 2023 | 380194 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 1060 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2009 | 84 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1992 | 772 | 0.020 |
Why?
|
| Zinc | 1 | 1993 | 684 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 212 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1991 | 865 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.020 |
Why?
|
| Phosphates | 1 | 1991 | 786 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2008 | 211 | 0.020 |
Why?
|
| Gene Products, vif | 1 | 2007 | 33 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2008 | 109 | 0.020 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 53 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9734 | 0.020 |
Why?
|
| Leupeptins | 1 | 2006 | 122 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1184 | 0.020 |
Why?
|
| Lymphocytes | 2 | 1994 | 2617 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2183 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1987 | 565 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2008 | 246 | 0.020 |
Why?
|
| Tyrosine | 1 | 1990 | 1461 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 63114 | 0.020 |
Why?
|
| Immune System | 1 | 2011 | 805 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1993 | 1990 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 252 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 377 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1990 | 987 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2007 | 316 | 0.020 |
Why?
|
| Amino Acids | 1 | 1990 | 1736 | 0.020 |
Why?
|
| Replication Origin | 1 | 2004 | 77 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2007 | 436 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3701 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 1692 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
| Species Specificity | 2 | 1997 | 2478 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.010 |
Why?
|
| Chromosomes | 1 | 2003 | 596 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 694 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5442 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 2803 | 0.010 |
Why?
|
| Lymphoma | 1 | 1988 | 1877 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1405 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2915 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1996 | 182 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1995 | 103 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1995 | 203 | 0.010 |
Why?
|
| Ribonuclease H | 1 | 1994 | 45 | 0.010 |
Why?
|
| Spectrin | 1 | 1995 | 177 | 0.010 |
Why?
|
| Solutions | 1 | 1995 | 426 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1994 | 293 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1988 | 4665 | 0.010 |
Why?
|
| Male | 2 | 2023 | 350118 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.010 |
Why?
|
| Lysine | 1 | 1997 | 1007 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1994 | 2255 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2006 | 6544 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40075 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 213383 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 214055 | 0.000 |
Why?
|